Safari Industries (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 5, 2025, 5:13 pm

Quick Insight

Safari Industries (India) Ltd's current market capitalization stands at ₹10,381 Cr., with a notable P/E ratio of 69.7, suggesting a premium valuation. The company's ROE and ROCE at 15.8% and 18.7% respectively indicate decent profitability and efficient capital utilization. With a healthy operating profit margin of 15% and strong net profit of ₹143 Cr., Safari Industries demonstrates operational efficiency. The company's significant reserves of ₹944 Cr. provide a cushion for future growth, although its borrowing of ₹125 Cr. warrants attention. Overall, Safari Industries presents a mixed picture of strong financial performance tempered by leverage, highlighting the need for prudent debt management in its growth strategy.

Competitors of Safari Industries (India) Ltd

All Competitor Stocks of Safari Industries (India) Ltd

Quarterly Result

Last Updated: August 20, 2025, 4:15 am

Below is a detailed analysis of the quarterly data for Safari Industries (India) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 528.00 Cr.. The value appears strong and on an upward trend. It has increased from 421.00 Cr. (Mar 2025) to 528.00 Cr., marking an increase of 107.00 Cr..
• For Expenses, as of Jun 2025, the value is 449.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 360.00 Cr. (Mar 2025) to 449.00 Cr., marking an increase of 89.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Mar 2025) to 79.00 Cr., marking an increase of 18.00 Cr..
• For OPM %, as of Jun 2025, the value is 15.00%. The value appears strong and on an upward trend. It has increased from 14.00% (Mar 2025) to 15.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
• For Interest, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 17.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15.00 Cr. (Mar 2025) to 17.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 65.00 Cr.. The value appears strong and on an upward trend. It has increased from 49.00 Cr. (Mar 2025) to 65.00 Cr., marking an increase of 16.00 Cr..
• For Tax %, as of Jun 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 24.00% (Mar 2025) to 23.00%, marking a decrease of 1.00%.
• For Net Profit, as of Jun 2025, the value is 50.00 Cr.. The value appears strong and on an upward trend. It has increased from 38.00 Cr. (Mar 2025) to 50.00 Cr., marking an increase of 12.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 10.33. The value appears strong and on an upward trend. It has increased from 7.69 (Mar 2025) to 10.33, marking an increase of 2.64.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:09 pm

Growth

Last Updated: September 5, 2025, 1:15 pm

Balance Sheet

Last Updated: July 25, 2025, 2:26 pm

Below is a detailed analysis of the balance sheet data for Safari Industries (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.00 Cr..
• For Reserves, as of Mar 2025, the value is 944.00 Cr.. The value appears strong and on an upward trend. It has increased from 814.00 Cr. (Mar 2024) to 944.00 Cr., marking an increase of 130.00 Cr..
• For Borrowings, as of Mar 2025, the value is 125.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 146.00 Cr. (Mar 2024) to 125.00 Cr., marking a decrease of 21.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 238.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 173.00 Cr. (Mar 2024) to 238.00 Cr., marking an increase of 65.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 1,316.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,143.00 Cr. (Mar 2024) to 1,316.00 Cr., marking an increase of 173.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 414.00 Cr.. The value appears strong and on an upward trend. It has increased from 293.00 Cr. (Mar 2024) to 414.00 Cr., marking an increase of 121.00 Cr..
• For CWIP, as of Mar 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 12.00 Cr., marking an increase of 11.00 Cr..
• For Investments, as of Mar 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 149.00 Cr. (Mar 2024) to 3.00 Cr., marking a decrease of 146.00 Cr..
• For Other Assets, as of Mar 2025, the value is 887.00 Cr.. The value appears strong and on an upward trend. It has increased from 700.00 Cr. (Mar 2024) to 887.00 Cr., marking an increase of 187.00 Cr..
• For Total Assets, as of Mar 2025, the value is 1,316.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,143.00 Cr. (Mar 2024) to 1,316.00 Cr., marking an increase of 173.00 Cr..

Notably, the Reserves (944.00 Cr.) exceed the Borrowings (125.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Safari Industries (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 29.24. This value is within the healthy range. It has decreased from 36.90 (Mar 24) to 29.24, marking a decrease of 7.66.
• For Diluted EPS (Rs.), as of Mar 25, the value is 29.16. This value is within the healthy range. It has decreased from 36.73 (Mar 24) to 29.16, marking a decrease of 7.57.
• For Cash EPS (Rs.), as of Mar 25, the value is 41.28. This value is within the healthy range. It has decreased from 46.69 (Mar 24) to 41.28, marking a decrease of 5.41.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 194.99. It has increased from 168.92 (Mar 24) to 194.99, marking an increase of 26.07.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 194.99. It has increased from 168.92 (Mar 24) to 194.99, marking an increase of 26.07.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 362.29. It has increased from 318.03 (Mar 24) to 362.29, marking an increase of 44.26.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 51.83. This value is within the healthy range. It has decreased from 59.78 (Mar 24) to 51.83, marking a decrease of 7.95.
• For PBIT / Share (Rs.), as of Mar 25, the value is 39.76. This value is within the healthy range. It has decreased from 49.15 (Mar 24) to 39.76, marking a decrease of 9.39.
• For PBT / Share (Rs.), as of Mar 25, the value is 37.95. This value is within the healthy range. It has decreased from 47.20 (Mar 24) to 37.95, marking a decrease of 9.25.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 29.20. This value is within the healthy range. It has decreased from 36.06 (Mar 24) to 29.20, marking a decrease of 6.86.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 29.20. This value is within the healthy range. It has decreased from 36.06 (Mar 24) to 29.20, marking a decrease of 6.86.
• For PBDIT Margin (%), as of Mar 25, the value is 14.30. This value is within the healthy range. It has decreased from 18.79 (Mar 24) to 14.30, marking a decrease of 4.49.
• For PBIT Margin (%), as of Mar 25, the value is 10.97. This value is within the healthy range. It has decreased from 15.45 (Mar 24) to 10.97, marking a decrease of 4.48.
• For PBT Margin (%), as of Mar 25, the value is 10.47. This value is within the healthy range. It has decreased from 14.84 (Mar 24) to 10.47, marking a decrease of 4.37.
• For Net Profit Margin (%), as of Mar 25, the value is 8.06. This value is within the healthy range. It has decreased from 11.33 (Mar 24) to 8.06, marking a decrease of 3.27.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.06. This value is within the healthy range. It has decreased from 11.33 (Mar 24) to 8.06, marking a decrease of 3.27.
• For Return on Networth / Equity (%), as of Mar 25, the value is 14.97. This value is below the healthy minimum of 15. It has decreased from 21.34 (Mar 24) to 14.97, marking a decrease of 6.37.
• For Return on Capital Employeed (%), as of Mar 25, the value is 18.63. This value is within the healthy range. It has decreased from 26.24 (Mar 24) to 18.63, marking a decrease of 7.61.
• For Return On Assets (%), as of Mar 25, the value is 10.82. This value is within the healthy range. It has decreased from 15.36 (Mar 24) to 10.82, marking a decrease of 4.54.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has decreased from 0.05 (Mar 24) to 0.02, marking a decrease of 0.03.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.44. It has decreased from 1.64 (Mar 24) to 1.44, marking a decrease of 0.20.
• For Current Ratio (X), as of Mar 25, the value is 3.15. This value exceeds the healthy maximum of 3. It has decreased from 3.56 (Mar 24) to 3.15, marking a decrease of 0.41.
• For Quick Ratio (X), as of Mar 25, the value is 1.88. This value is within the healthy range. It has decreased from 2.40 (Mar 24) to 1.88, marking a decrease of 0.52.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 4. It has increased from 1.72 (Mar 24) to 1.91, marking an increase of 0.19.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 6.08 (Mar 24) to 0.00, marking a decrease of 6.08.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 4.69 (Mar 24) to 0.00, marking a decrease of 4.69.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 93.92 (Mar 24) to 0.00, marking a decrease of 93.92.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 95.31 (Mar 24) to 0.00, marking a decrease of 95.31.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 28.67. This value is within the healthy range. It has decreased from 30.67 (Mar 24) to 28.67, marking a decrease of 2.00.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 17.15. This value is within the healthy range. It has decreased from 19.51 (Mar 24) to 17.15, marking a decrease of 2.36.
• For Enterprise Value (Cr.), as of Mar 25, the value is 9,464.50. It has increased from 8,236.98 (Mar 24) to 9,464.50, marking an increase of 1,227.52.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.34. This value exceeds the healthy maximum of 3. It has increased from 5.31 (Mar 24) to 5.34, marking an increase of 0.03.
• For EV / EBITDA (X), as of Mar 25, the value is 37.34. This value exceeds the healthy maximum of 15. It has increased from 28.27 (Mar 24) to 37.34, marking an increase of 9.07.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.46. This value exceeds the healthy maximum of 3. It has increased from 5.43 (Mar 24) to 5.46, marking an increase of 0.03.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 93.91 (Mar 24) to 0.00, marking a decrease of 93.91.
• For Price / BV (X), as of Mar 25, the value is 10.14. This value exceeds the healthy maximum of 3. It has decreased from 10.22 (Mar 24) to 10.14, marking a decrease of 0.08.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.46. This value exceeds the healthy maximum of 3. It has increased from 5.43 (Mar 24) to 5.46, marking an increase of 0.03.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness